Developer docs
API playgroundTry for free, no card

Search company profiles

TMC Group

Full company profile

uuid028c5h9

Namestring
TMC Group
Legal namestring
TMC Group
Websiteurl
tmc-group.ca
Company typeenum
Private
Founded yearint
2004
Descriptiontext

TMC Group is a privately held Canadian specialty manufacturer founded in 2004 and headquartered in North Vancouver, British Columbia. The company manufactures high-purity enriched stable isotopes — currently Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104 — that serve as the starting materials for medical radioisotopes used in targeted cancer therapies (notably Lutetium-177 and the emerging Terbium-161) and diagnostic imaging. Production is performed at a 30,000+ square-foot integrated facility using proprietary isotope-manufacturing technologies, custom in-house equipment, and specialized production processes, achieving demonstrated isotopic purity of up to 99.9%. Cumulative shipments exceed 13 kg since 2004, with 2025 output of over 2 kg of Yb-176 at 99.7%+ purity and a near-1 kg Ga-69 run in 2026. The company emphasizes its Western, geopolitically stable supply base as a differentiated alternative to incumbent producers concentrated in volatile regions.

Short descriptiontext

TMC Group is a Canadian manufacturer of high-purity enriched stable isotopes (Yb-176, Ga-69, Gd-160, Pd-104) used as starting materials for medical radioisotopes in cancer therapy and diagnostics, selling globally to radiopharmaceutical companies, biotech firms, and research institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNorth Vancouver, Canada
HQ citystring
North Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stable isotope manufacturing, enriched isotope production, medical radioisotope supply, Ytterbium-176 production, isotope enrichment technology
Industry2 codes
PRIMARYEUAKAIAA
Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)
SECONDARYEUAKAIAE
Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)
NAICS code2 codes
  • Ground or Treated Mineral and Earth Manufacturing327992
  • Chemical Manufacturing325
SIC code1 code
  • Miscellaneous Chemical Products2890
Product category
Stable Isotope Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1High-Purity Stable Isotope Sales
TypeOne Time License
Description

One-time product sales of manufactured stable isotopes including Ytterbium-176, Gallium-69, and Gadolinium-160. Sold in various quantities from small research-scale batches to large commercial volumes. Customers include radiopharmaceutical companies, biotech firms, research institutions, and isotope distributors worldwide.

tmc-group.ca
2Custom Isotope Manufacturing
TypeOne Time License
Description

Bespoke manufacturing services adapting proprietary technologies and processes to produce specialized stable isotopes as required by customers. Flexibility to adjust production based on specific customer demands.

tmc-group.ca
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

TMC Group manufactures high-purity enriched stable isotopes, including Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104, for use in medical radioisotope production and scientific research. The company operates a specialty manufacturing facility in North Vancouver, British Columbia, and ships its isotope products to customers worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99.9% isotopic purity achieved
+4 more records
Product overview1 text field

TMC Group is a manufacturer of high-purity enriched stable isotopes that offers a portfolio of non-radioactive isotopes including Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104. The company's products are manufactured using proprietary isotope-manufacturing technologies, custom equipment designed in-house, and specialized production processes. TMC Group's stable isotopes serve as essential starting materials for creating medical radioisotopes used in targeted cancer treatments and diagnostic applications. The company produces isotopes at demonstrated isotopic purity reaching up to 99.9%, with production capabilities ranging from small research-scale batches to large commercial volumes. The company operates a 30,000+ square-foot isotope production facility in North Vancouver, Canada.

Product and service4 records
1Ytterbium-176 (Yb-176)
CategoryStable Isotope
2Gallium-69 (Ga-69)
CategoryStable Isotope
3Gadolinium-160 (Gd-160)
CategoryStable Isotope
4Palladium-104 (Pd-104)
CategoryStable Isotope
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
TypeOthersAnnounced on2025-08-07
Description

TMC Group joined CNIC to be part of a growing national effort to strengthen Canada's isotope supply chain. CNIC has over 110 members from across Canada's isotope supply chain. TMC Group will participate in federal and provincial advocacy opportunities, in-person and virtual events, and educational programming. CNIC's goal is to double Canadian isotope production by 2030 as outlined in the Isotopes for Hope campaign.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
TypeEmerging player
Description

Emerging medical isotope producer using fusion-based neutron generation. Competes with established supply for Mo-99/Lu-177 and represents a next-generation alternative to traditional reactor-based production.

TypeDirect peer
Description

Largest commercial manufacturer of enriched stable isotopes for research, medical, and industrial applications. Most directly comparable to TMC as a pure-play stable isotope producer with global customers in pharma and life sciences.

TypeDirect peer
Description

Producer of stable isotopes and isotope-labeled compounds for research, diagnostics, and pharmaceuticals. Comparable to TMC as a specialty isotope manufacturer serving similar end markets.

TypeBroad incumbent
Description

European uranium enrichment company with stable isotope production capabilities. Operates at far larger scale than TMC in the broader isotope value chain.

TypeBroad incumbent
Description

Diversified nuclear technology company with a medical isotope and radiopharmaceutical manufacturing segment. Larger-scale competitor in the medical isotope supply chain.

6Nordion
TypeBroad incumbent
Description

Canadian-based medical isotope supplier producing radioisotopes including Mo-99. Shares TMC's Canadian heritage and radiopharma customer base, though downstream in the value chain.

TypeDirect peer
Description

Canadian-based manufacturer of enriched stable isotopes serving research, industrial, and medical applications. Directly comparable in scale and product mix to TMC.

TypeBroad incumbent
Description

Global life science and specialty chemicals supplier offering a broad catalog of stable isotopes alongside a much wider chemicals and reagents portfolio. Competes with TMC in research-grade isotope supply.

TypeBroad incumbent
Description

Global nuclear medicine company producing radiopharmaceuticals and medical isotopes for diagnostic imaging. Downstream competitor in the radiopharma value chain feeding similar end customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TMC Group

Stable Isotope Manufacturingtmc-group.ca

TMC Group is a Canadian manufacturer of high-purity enriched stable isotopes (Yb-176, Ga-69, Gd-160, Pd-104) used as starting materials for medical radioisotopes in cancer therapy and diagnostics, selling globally to radiopharmaceutical companies, biotech firms, and research institutions.

What TMC Group does

TMC Group is a privately held Canadian specialty manufacturer founded in 2004 and headquartered in North Vancouver, British Columbia. The company manufactures high-purity enriched stable isotopes — currently Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104 — that serve as the starting materials for medical radioisotopes used in targeted cancer therapies (notably Lutetium-177 and the emerging Terbium-161) and diagnostic imaging. Production is performed at a 30,000+ square-foot integrated facility using proprietary isotope-manufacturing technologies, custom in-house equipment, and specialized production processes, achieving demonstrated isotopic purity of up to 99.9%. Cumulative shipments exceed 13 kg since 2004, with 2025 output of over 2 kg of Yb-176 at 99.7%+ purity and a near-1 kg Ga-69 run in 2026. The company emphasizes its Western, geopolitically stable supply base as a differentiated alternative to incumbent producers concentrated in volatile regions.

TMC Group firmographics

Firmographics
Name
TMC Group
Legal name
TMC Group
Website
https://tmc-group.ca
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
TMC Group is a Canadian manufacturer of high-purity enriched stable isotopes (Yb-176, Ga-69, Gd-160, Pd-104) used as starting materials for medical radioisotopes in cancer therapy and diagnostics, selling globally to radiopharmaceutical companies, biotech firms, and research institutions.
Ownership category
akta.pro rank

TMC Group industry classification

Industry
Product category
Stable Isotope Manufacturing
NAICS
Ground or Treated Mineral and Earth Manufacturing (327992), Chemical Manufacturing (325)
SIC
Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYEUAKAIAA
Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)
SECONDARYEUAKAIAE
Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)

Keywords

  • Stable isotope manufacturing
  • Enriched isotope production
  • Medical radioisotope supply
  • Ytterbium-176 production
  • Isotope enrichment technology

Where TMC Group is headquartered

Location

Headquarters

HQ city
North Vancouver
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

TMC Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

  1. High-Purity Stable Isotope Sales: One-time product sales of manufactured stable isotopes including Ytterbium-176, Gallium-69, and Gadolinium-160. Sold in various quantities from small research-scale batches to large commercial volumes. Customers include radiopharmaceutical companies, biotech firms, research institutions, and isotope distributors worldwide.
  2. Custom Isotope Manufacturing: Bespoke manufacturing services adapting proprietary technologies and processes to produce specialized stable isotopes as required by customers. Flexibility to adjust production based on specific customer demands.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

TMC Group product offering

Product offering

Core offering

TMC Group manufactures high-purity enriched stable isotopes, including Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104, for use in medical radioisotope production and scientific research. The company operates a specialty manufacturing facility in North Vancouver, British Columbia, and ships its isotope products to customers worldwide.

Product overview

TMC Group is a manufacturer of high-purity enriched stable isotopes that offers a portfolio of non-radioactive isotopes including Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104. The company's products are manufactured using proprietary isotope-manufacturing technologies, custom equipment designed in-house, and specialized production processes. TMC Group's stable isotopes serve as essential starting materials for creating medical radioisotopes used in targeted cancer treatments and diagnostic applications. The company produces isotopes at demonstrated isotopic purity reaching up to 99.9%, with production capabilities ranging from small research-scale batches to large commercial volumes. The company operates a 30,000+ square-foot isotope production facility in North Vancouver, Canada.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ytterbium-176 (Yb-176)
  • Gallium-69 (Ga-69)
  • Gadolinium-160 (Gd-160)
  • Palladium-104 (Pd-104)

Quantifiable outcome

  • 99.9% isotopic purity achieved
  • +4 more outcomes

Companies that use TMC Group

Customer profile

Segments5 records

Ideal customer profiles2 records

TMC Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

TMC Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Canadian Nuclear Isotope Council (CNIC)Others · 7 August 2025TMC Group joined CNIC to be part of a growing national effort to strengthen Canada's isotope supply chain. CNIC has over 110 members from across Canada's isotope supply chain. TMC Group will participate in federal and provincial advocacy opportunities, in-person and virtual events, and educational programming. CNIC's goal is to double Canadian isotope production by 2030 as outlined in the Isotopes for Hope campaign.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

TMC Group competitors and assessment

Company assessment

Emerging players

  • SHINE Technologies: Emerging medical isotope producer using fusion-based neutron generation. Competes with established supply for Mo-99/Lu-177 and represents a next-generation alternative to traditional reactor-based production.

Direct peers

  • Cambridge Isotope Laboratories: Largest commercial manufacturer of enriched stable isotopes for research, medical, and industrial applications. Most directly comparable to TMC as a pure-play stable isotope producer with global customers in pharma and life sciences.
  • Isoflex: Producer of stable isotopes and isotope-labeled compounds for research, diagnostics, and pharmaceuticals. Comparable to TMC as a specialty isotope manufacturer serving similar end markets.
  • Trace Sciences International: Canadian-based manufacturer of enriched stable isotopes serving research, industrial, and medical applications. Directly comparable in scale and product mix to TMC.

Broad incumbents

  • URENCO: European uranium enrichment company with stable isotope production capabilities. Operates at far larger scale than TMC in the broader isotope value chain.
  • BWXT Medical: Diversified nuclear technology company with a medical isotope and radiopharmaceutical manufacturing segment. Larger-scale competitor in the medical isotope supply chain.
  • Nordion: Canadian-based medical isotope supplier producing radioisotopes including Mo-99. Shares TMC's Canadian heritage and radiopharma customer base, though downstream in the value chain.
  • Sigma-Aldrich (Merck KGaA): Global life science and specialty chemicals supplier offering a broad catalog of stable isotopes alongside a much wider chemicals and reagents portfolio. Competes with TMC in research-grade isotope supply.
  • Curium: Global nuclear medicine company producing radiopharmaceuticals and medical isotopes for diagnostic imaging. Downstream competitor in the radiopharma value chain feeding similar end customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

TMC Group social profiles

Digital presence

TMC Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TMC Group leadership team

Management profile

Number of profiles

Profiles2 records

TMC Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TMC Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TMC Group

What does TMC Group do?

TMC Group manufactures high-purity enriched stable isotopes, including Ytterbium-176, Gallium-69, Gadolinium-160, and Palladium-104, for use in medical radioisotope production and scientific research. The company operates a specialty manufacturing facility in North Vancouver, British Columbia, and ships its isotope products to customers worldwide.

Is TMC Group a public or private company?

TMC Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TMC Group founded?

TMC Group was founded in 2004. It employs 11 to 50 people.

Where is TMC Group based?

TMC Group is headquartered in North Vancouver, Canada, in the North America region.

How does TMC Group make money?

Two revenue lines are on record. High-Purity Stable Isotope Sales are the primary driver. The others are custom Isotope Manufacturing.

Who are TMC Group's main competitors?

SHINE Technologies is listed as an emerging player. Direct peers are Cambridge Isotope Laboratories, Isoflex and Trace Sciences International. Broad incumbents are URENCO, BWXT Medical, Nordion, Sigma-Aldrich (Merck KGaA) and Curium.

Does TMC Group have an API?

No public API is recorded for TMC Group.

What industry is TMC Group in?

TMC Group's product category is Stable Isotope Manufacturing. Its primary akta.pro industry code is EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.), with a secondary code of EUAKAIAE, Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain). Its NAICS code is 327992 and its SIC code is 2890.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals